Provention Bio Inc.

NASDAQ: PRVB · Real-Time Price · USD
24.98
0.00 (0.00%)
At close: Apr 26, 2023, 10:00 PM

Provention Bio Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2022 FY 2021
Period Ending Dec 31, 2022 Dec 31, 2021
Net Income
-113.56M -114.43M
Depreciation & Amortization
1.23M 387K
Stock-Based Compensation
19.03M 11.84M
Other Working Capital
17.31M 10.34M
Other Non-Cash Items
-36K -37K
Deferred Income Tax
n/a 538K
Change in Working Capital
17.94M 6.32M
Operating Cash Flow
-75.41M -95.39M
Capital Expenditures
-795K -961K
Cash Acquisitions
n/a n/a
Purchase of Investments
-103.08M -55.28M
Sales Maturities Of Investments
30.75M 25.15M
Other Investing Acitivies
-15M n/a
Investing Cash Flow
-88.13M -31.1M
Debt Repayment
n/a n/a
Common Stock Repurchased
n/a n/a
Dividend Paid
n/a n/a
Other Financial Acitivies
129.38M 102.38M
Financial Cash Flow
129.38M 102.38M
Net Cash Flow
-34.15M -24.1M
Free Cash Flow
-76.2M -96.35M